corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published in 2009

There are 1996 items in the Healthy Skepticism Library that were published in 2009.

Page 3 of 20 pages  < 1 2 3 4 5 >  Last ›

HSL16914
Iskowitz M
Lupus drug launch focuses on social media, advocacy orgs
Medical Marketing & Media 2009 Nov 4
http://www.mmm-online.com/lupus-drug-launch-focuses-on-social-media-advocacy-orgs/article/157065/

HSL16759
Robertson J, Moynihan R, Walkom E, Bero L, Henry D
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Med 2009 Nov 3; 6:(11):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000128

HSL16760
Mayor S
Report calls for public education on screening to ensure more realistic expectations
BMJ 2009 11 03; 339:
http://www.bmj.com/cgi/content/short/339/nov03_1/b4533?rss=1

HSL16803
Arbour D
Sweet nothings
PM Live 2009 Nov 3
http://www.pmlive.com/find_an_article/allarticles/categories/General/2009/november/features/sweet_nothings

HSL16902
Singer N
Health Bills Aim a Light on Doctors’ Conflicts
The New York Times 2009 Nov 3
http://www.nytimes.com/2009/11/04/health/policy/04sunshine.html?_r=1

HSL17051
Dyer C
Professor is charged with dishonesty over statements on access to full trial data
BMJ 2009 Nov 3;
http://www.bmj.com/cgi/content/extract/339/nov03_2/b4556

HSL16783
Silverman E
Drugmakers Place Caps On Speaker Fees: Study
Pharmalot 2009 Nov 2
http://www.pharmalot.com/2009/11/drugmakers-place-caps-on-speaker-fees-study/

HSL16761
Rosenberg M
Aren't You Glad Your Doctor Completed Pharma's CMEs?
OpEdNews 2009 Nov 1
http://www.opednews.com/articles/1/Aren-t-You-Glad-Your-Docto-by-Martha-Rosenberg-091101-548.html

HSL16762
Shuaibu I
$75m: Pfizer Demands DNA Report from Beneficiaries
This Day 2009 Nov 1
http://www.nigerianelitesforum.com/ng/health/254-75-million-for-kano-meningitis-trovan-test-victims.html

HSL16903
Moses L
Magazine Industry Hooked on Pharma?
Media Week 2009 Nov 1
http://www.mediaweek.com/mw/content_display/news/magazines-newspapers/e3i26911e62ce1ee0f79f8ed9795df25657

HSL16763
Carmichael M
Bitter Pills
Boston Magazine 2009 Nov
http://www.bostonmagazine.com/articles/bitter_pills/page1

HSL16796
Charlton BG
Are you an honest scientist? Truthfulness in science should be an iron law, not a vague aspiration.
Med Hypotheses 2009 Nov; 73:(5):633-5
http://linkinghub.elsevier.com/retrieve/pii/S0306-9877(09)00342-9

HSL16809
Brownlee S, Lenzer J
Does the Vaccine Matter?
The Atlantic 2009 Nov
http://www.theatlantic.com/doc/200911/brownlee-h1n1

HSL16844
Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight
The Center for Health & Pharmaceutical Law & Policy 2009 Nov
http://law.shu.edu/ProgramsCenters/HealthTechIP/upload/health_center_whitepaper_nov2009.pdf

HSL16872
Levinson DR
How Grantees Manage Financial Conflicts Of Interest In Research Funded By The National Institutes Of Health
Department of Health and Human Services 2009 Nov
http://oig.hhs.gov/oei/reports/oei-03-07-00700.pdf

HSL16939
Sierles F, Brodkey A, Cleary L, McCurdy FA, Mintz M, Frank J, Lynn DJ, Chao J, Morgenstern B, Shore W, Woodard J.
Relationships between drug company representatives and medical students: medical school policies and attitudes of student affairs deans and third-year medical students.
Acad Psychiatry 2009 Nov-Dec; 33:(6):478-83
http://ap.psychiatryonline.org/cgi/content/full/33/6/478

HSL16869
Tfelt-Hansen PC
Unpublished clinical trials with sumatriptan
The Lancet 2009 Oct 31; 374:(9700):1501 - 1502
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61906-1/fulltext

HSL16765
Shire Subpoenaed In U.S. Drug Marketing Probe
The Wall Street Journal 2009 Oct 30
http://web.archive.org/web/20100124190008/http://online.wsj.com/article/BT-CO-20091030-713715.html

HSL16784
Silverman E
Amgen Sued By 15 States Over Aranesp Kickbacks
Pharmalot 2009 Oct 30
http://www.pharmalot.com/2009/10/amgen-sued-by-15-states-over-aranesp-kickbacks/

HSL16785
Silverman E
AstraZeneca Pays $520M To Settle Seroquel Probes
Pharmalot 2009 Oct 30
http://www.pharmalot.com/2009/10/astrazeneca-pays-520m-to-settle-seroquel-probes/

HSL16909
Wilson D
AstraZeneca Pays Millions to Settle Seroquel Cases
The New York Times 2009 Oct 30
http://www.nytimes.com/2009/10/30/business/30drug.html?pagewanted=print

HSL19024
Shwartz LM, Woloshin S.
Lost in transmission--FDA drug information that never reaches clinicians.
Engl J Med 2009 Oct 29; 361:(18):1717-20
http://www.nejm.org/doi/full/10.1056/NEJMp0907708

HSL16756
Garuba HA, Kohler JC, Huisman AM
Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers
Globalization and Health 2009 Oct 29; 5:(1):14
http://www.globalizationandhealth.com/content/5/1/14/abstract

HSL16767
AstraZeneca starts to come clean about Seroquel
Pharma Gossip 2009 Oct 29
http://pharmagossip.blogspot.com/2009/10/astrazeneca-starts-to-come-clean-about.html

HSL16770
Iniciativas para diminuir relação entre médicos e indústria farmacêutica - III Congresso Brasileiro sobre Uso Racional de Medicamentos
2009 Oct 29
http://www.ceara.gov.br/?secretaria=ALBERT_SABIN&endereco=http://www.albertsabin.ce.gov.br/noticias/14-lista-de-noticias/269--congresso-debate-etica-no-uso-racional-de-medicamentos

HSL16695
Campbell EG, Rosenthal M
Reform of Continuing Medical Education: Investments in Physician Human Capital
JAMA 2009 Oct 28; 302:(16):
http://jama.ama-assn.org/cgi/content/extract/302/16/1807

HSL16696
Maddern G
Diary of a surgeon: doctors on the market?
Crikey 2009 Oct 28
www.crikey.com.au/2009/10/28/diary-of-a-surgeon-doctors-on-the-market/

HSL16766
Martin JP, Cronin Fisk M, Voreacos D
J&J Salesman Says He Sold Drug for Unapproved Uses (Update3)
Bloomberg.com 2009 Oct 28
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aizNbBG7bmZg

HSL16786
Silverman E
FDA Warns Sanofi-Aventis Over Misleading Material
Pharmalot 2009 Oct 28
http://www.pharmalot.com/2009/10/fda-warns-sanofi-aventis-over-misleading-material/

HSL16915
Comer B
Sanofi card trick draws warning
Medical Marketing & Media 2009 Oct 28
http://www.mmm-online.com/sanofi-card-trick-draws-warning/article/156355/

HSL17527
Gever J
FDA Oversight of Postmarketing Studies Slammed
MedPage Today 2009 Oct 28
http://www.medpagetoday.com/PublicHealthPolicy/HealthPolicy/16670

HSL16685
Pringle E
Profit Driven Swine Flu Propaganda - Pump Up the Volume - Part Four
Natural News 2009 Oct 27
http://www.naturalnews.com/027336_swine_flu_health_propaganda.html

HSL16689
Favole JA
Grassley Probe Of Health Group May Show Deeper Pharma Ties
Dow Jones Newswires 2009 Oct 27
http://www.nasdaq.com/aspx/stock-market-news-story.aspx?storyid=200910221848dowjonesdjonline001058&title=grassley-probe-

HSL16680
Williamson S, McGrath S, Pound A
Joint working with the pharmaceutical industry
Health Service Journal 2009 Oct 26
http://www.hsj.co.uk/resource-centre/your-ideas-and-suggestions/joint-working-with-the-pharmaceutical-industry/5006877.article

HSL16681
Silverman E
NAMI: AstraZeneca Is A ‘Strong, Effective Partner’
Pharmalot 2009 Oct 26
http://www.pharmalot.com/2009/10/nami-astrazeneca-is-a-strong-effective-partner/

HSL16682
Pitts P
'Shaming' is good. Prison is better.
DrugWonks.com 2009 Oct 26
http://www.drugwonks.com/blog_post/show/7030

HSL16687
Jack A
GlaxoSmithKline sidesteps NICE by negotiating with individual hospitals
BMJ 2009 Oct 26; 339:
http://www.bmj.com/cgi/content/extract/339/oct26_1/b4406

HSL16688
Hopkins Tanne J
Merck discloses $3.7m paid to US doctors for speeches over three months
BMJ 2009 Oct 26; 339:
http://www.bmj.com/cgi/content/extract/339/oct26_1/b4409

HSL16658
Scannell K
Educating doctors -- When Pharma writes the script
The Oakland Tribune 2009 Oct 24
http://www.insidebayarea.com/opinion/ci_13627454

HSL16677
Harvey K
Therapeutic goods reform a bitter pill
The Australian 2009 Oct 24
http://www.theaustralian.news.com.au/story/0,25197,26245931-23289,00.html

HSL16657
Branded Websites Offer Benefits To Pharmaceutical Marketing, Among Others
B2B Marketing News 2009 Oct 23
http://www.komarketingassociates.com/industry-news/branded-websites-offer-benefits-to-pharmaceutical-marketing-among-others$311.htm

HSL16670
Benesh P
Pharma Seeks Cure For Off-Label Woes
Yahoo Finance 2009 Oct 23
http://pharmagossip.blogspot.com/2009/10/pharma-seeks-cure-for-off-label-woes.html

HSL16671
Associated Press
Eli Lilly Settles Zyprexa Suit With South Carolina
The New York Times 2009 Oct 23
http://www.nytimes.com/2009/10/24/business/24bizbriefs-ELILILLYSETT_BRF.html?_r=1

HSL16672
McCaughan M
Alergan’s First Amendment Case: REMS vs. Off-Label Promotion – and DTC
Invivo Blog 2009 Oct 23
http://invivoblog.blogspot.com/2009/10/allergans-first-amendment-case-rems-vs.html

HSL16675
Pringle E
Profit Driven Swine Flu Propaganda - Pump Up the Volume Part 3
Natural News 2009 Oct 23
http://web.archive.org/web/20100810184035/http://www.naturalnews.com/027310_swine_flu_health_Tamiflu.html

HSL16674
Pringle E
Profit Drive Swine Flu Propaganda - Pump Up the Volume - Part 2
Natural News 2009 Oct 22
http://web.archive.org/web/20100110110350/http://www.naturalnews.com/027301_swine_flu_influenza_pandemic.html

HSL16676
Perrone M
Experts: Key drug facts often left off FDA labels
The Associated Press 2009 Oct 22
http://www.cbsnews.com/stories/2009/10/21/health/main5407280.shtml

HSL16692
Taylor L
EU slammed for “double standards” over generics
Pharma Times 2009 Oct 22
http://www.pharmatimes.com/WorldNews/article.aspx?id=16779

HSL16646
Thomaselli R
Franken and Senate Democrats Go After Tax Deduction for Advertising
The Advertising Age 2009 Oct 21
http://adage.com/article?article_id=139826

HSL16649
Arnold M
King warned on Embeda VNRs
Medical Marketing & Media 2009 Oct 21
http://www.mmm-online.com/King-warned-on-Embeda-VNRs/article/155905/

HSL16650
Kuehn BM
Despite Health Claims by Manufacturers, Little Oversight for Homeopathic Products
JAMA 2009 Oct 21; 302:(15):1631-1634.
http://jama.ama-assn.org/cgi/content/extract/302/15/1631

HSL16654
Harris G
Drug Makers Are Advocacy Group’s Biggest Donors
The New York Times 2009 Oct 21
http://www.nytimes.com/2009/10/22/health/22nami.html?_r=1

HSL16665
Bion J.
Financial and intellectual conflicts of interest: confusion and clarity.
Curr Opin Crit Care 2009 Oct 21;
http://www.ncbi.nlm.nih.gov/pubmed/19851102

HSL16667
Mundae MK, Ostor AJ.
The long road of biopharmaceutical drug development: from inception to marketing.
QJM 2009 Oct 21;
http://www.ncbi.nlm.nih.gov/pubmed/19846578

HSL16673
Pringle E
Profit Driven Swine Flu Propaganda - Pump Up the Volume Part 1
Natural News 2009 Oct 21
http://www.naturalnews.com/027294_flu_vaccine_swine.html

HSL16690
Schwartz LM, Woloshin S
Lost in Transmission — FDA Drug Information That Never Reaches Clinicians
NEJM 2009 Oct 21;
http://healthcarereform.nejm.org/?p=2126

HSL17143
New Commercial Model: Science or Swag?
Deloitte 2009 Oct 21
http://www.deloitte.com/us/debates/scienceorswag

HSL16651
Johnson LA
Merck starts revealing payments to doctor-speakers
The Associated Press 2009 Oct 20
http://today.msnbc.msn.com/id/33384490/ns/today-today_health/t/drugmaker-reveals-which-docs-it-paid-speak/#.TxPkcm_9PQk

HSL16652
Comer B
Merck discloses a portion of US speaker fees
Medical Marketing & Media 2009 Oct 20
http://www.mmm-online.com/Merck-discloses-a-portion-of-US-speaker-fees/article/155779/

HSL16653
O'Reilly G
Google Sidewiki Could Damage Corporate Brand Reputations
PR Week 2009 Oct 20
http://www.prweek.com/channel/Technology/article/947139/Google Sidewiki could damage corporate brand reputat

HSL16683
Wilson D
Steps to Greater Accountability in Medical Education
The New York Times 2009 Oct 20
http://www.nytimes.com/2009/10/21/business/21medic.html?_r=1

HSL16805
New online qualitative research
PM Live 2009 Oct 20
http://www.pmlive.com/find_an_article/allarticles/categories/pr_and_med_ed/2009/october/news/new_online_qualitative_research

HSL16859
Vastag B
Drug Companies Used Physician Education to Push Pills
Brian Vastag 2009 Oct 20
http://brianvastag.net/2009/10/cme/

HSL16686
Medidas da Anvisa podem beneficiar Drogasil e Hypermarcas, diz Fator: Restrições podem consolidar a liderança de empresas que já atuam com força no setor
Portal Exame 2009 Oct 19
http://portalexame.abril.com.br/negocios/medidas-anvisa-podem-beneficiar-drogasil-hypermarcas-diz-fator-506616.html?page

HSL16691
Silverman E
Congresswoman: Deny Pfizer Any Federal Funding
Pharmalot 2009 Oct 19
http://www.pharmalot.com/2009/10/congresswoman-deny-pfizer-any-federal-funding/

HSL16643
Farmácia só pode vender remédio, decide STJ
Dom 2009 Oct 18
http://tinyurl.com/ygw3ypa

HSL16684
Russell J
Lilly pays CVS Caremark to try to get doctors to prescribe Cymbalta
IndyStar.com 2009 Oct 18
http://www.indystar.com/article/20091018/BUSINESS03/910180396/1003/BUSINESS/Lilly+pays+CVS+Caremark+to+try+to+get+doctor

HSL16641
Edwards J
DOJ Blames Pfizer Management for Bextra Mess:
BNet 2009 Oct 16
http://industry.bnet.com/pharma/10004867/doj-blames-pfizer-management-for-bextra-mess-the-goal-was-to-avoid-getting-caught/

HSL16693
Pelofsky J, Bishopric C
US court imposes penalties on Pfizer unit in Bextra case
Reuters 2009 Oct 16
http://www.reuters.com/article/rbssHealthcareNews/idUSN1636788820091016

HSL16694
Ziganshina LE
Putin criticises drug companies for paying doctors to prescribe their drugs
BMJ 2009 Oct 16; 339:
http://www.bmj.com/cgi/content/extract/339/oct16_2/b4200

HSL16642
Lawsuit Claims Execs Knew Vytorin Study Wouldn’t Be Favorable
newsinferno.com 2009 Oct 15
http://www.yourlawyer.com/articles/title/lawsuit-claims-execs-knew-vytorin-study-wouldnt-be-favorable

HSL16946
Cohen A
Big Pharma and Google Sidewiki: A Sink or Swim Situation?
The Advertising Age 2009 Oct 15
http://adage.com/digitalnext/article?article_id=139687

HSL16634
Mack J
Boehringer's Branded Tweet Violates FDA Regulations Just Like Those 14 Paid Search Ads Did
Pharma Marketing Blog 2009 Oct 14
http://pharmamkting.blogspot.com/2009/10/boehringers-branded-tweet-violates-fda.html

HSL16635
Greenhalgh T
The Ribena girls
BMJ 2009 Oct 14; 339:
http://www.bmj.com/cgi/content/extract/339/oct14_2/b4136

HSL16636
Martyn C
Don’t give up the ghost
BMJ 2009 Oct 14; 339:
http://www.bmj.com/cgi/content/extract/339/oct14_2/b4214

HSL16645
Wohl J, Heavey S
UPDATE 4-FDA warns P&G over vitamin C in DayQuil and NyQuil
Reuters 2009 Oct 14
http://www.reuters.com/article/rbssHealthcareNews/idUSN1425515720091014

HSL16628
Hunt S
Drug companies accused of indirect marketing to consumers
The Wire 2009 Oct 13
http://www.thewire.org.au/daydetail.aspx?SearchDay=2009-10-13

HSL16629
Goldstein J
See Your Doctor: The Dawn of Consumer Drug Ads
The Wall Street Journal Blog 2009 Oct 13
http://blogs.wsj.com/health/2009/10/13/see-your-doctor-the-dawn-of-consumer-drug-ads/

HSL16630
Drazen JM, Van Der Weyden MB, Sahni P, Rosenberg J, Marusic A, Laine C, Kotzin S, Horton R, Hébert PC, Haug C, Godlee F, Frizelle FA, de Leeuw PW, DeAngelis CD
Uniform Format for Disclosure of Competing Interests in ICMJE Journals
JAMA 2009 Oct 13; 303:(1):
http://jama.ama-assn.org/cgi/content/extract/2009.1542v1

HSL16631
Feeley J, Pearson S
Glaxo Ordered to Pay $2.5 Million for Paxil Defects (Update4)
Bloomberg.com 2009 Oct 13
http://www.bloomberg.com/apps/news?pid=20601087&sid=aVU8D0AZ.zS8

HSL16632
Staton T
Lawsuit: Schering execs sat on Vytorin results
Fierce Pharma 2009 Oct 13
http://www.fiercepharma.com/story/lawsuit-schering-execs-sat-vytorin-results/2009-10-13

HSL16633
Tuffs A
Leading German doctors criticise rising use of post-marketing observational studies by drug companies
BMJ 2009 Oct 13; 339:
http://www.bmj.com/cgi/content/extract/339/oct13_2/b4199

HSL16637
Spiegel A
Selling Sickness: How Drug Ads Changed Health Care
npr 2009 Oct 13
http://www.npr.org/templates/story/story.php?storyId=113675737

HSL16668
Chimonas S, Rozario NM, Rothman DJ.
Show Us the Money: Lessons in Transparency from State Pharmaceutical Marketing Disclosure Laws.
Health Serv Res 2009 Oct 13;
http://www.ncbi.nlm.nih.gov/pubmed/19840133

HSL16621
Carroll B
Nemeroff, Seroquel, and ACCME
Health Care Renewal Blog 2009 Oct 12
http://hcrenewal.blogspot.com/2009/10/nemeroff-seroquel-and-accme.html

HSL16622
Shankar P
Pharma companies play loyalty card to boost sales
NJBiz 2009 Oct 12
http://www.allbusiness.com/marketing-advertising/marketing-techniques/13364577-1.html

HSL16620
Barlow D
Drug firm comes to call in Vt. with cash
The Times Argus 2009 Oct 11
http://www.timesargus.com/article/20091011/NEWS01/910110347/1002/NEWS01

HSL16627
Webb J
US Health Reform: Beware of Side Effects!
BBC Radio 4 2009 Oct 11
http://www.bbc.co.uk/programmes/b00n8ss0

HSL16619
Martin J
Big banks, big pharma, big problems
New Scientist 2009 Oct 10
http://www.newscientist.com/article/mg20427295.500-big-banks-big-pharma-big-problems.html

HSL16623
Grimm F
Foster kids, prescriptions -- finally alarm
The Miami Herald 2009 Oct 10
http://www.mindfreedomireland.com/new/index.php?option=com_content&view=article&id=595:miami-herald&catid=1:administrator

HSL16613
Johnson LA
Study: Global prescription drug sales growth slows
The Associated Press 2009 Oct 9
http://www.memphisdailynews.com/editorial/ArticleEmail.aspx?id=45288

HSL16616
Abnormal practice of relationship between manufacturers of medicines and some part of medical community has become usual in Russia - Putin В России сложилась ненормальная практика взаимоотношений между производителями лекарств и частью врачебного сообщества - Путин
IFX-News 2009 Oct 9
http://www.finmarket.ru/z/nws/news.asp?id=1304854

HSL16788
Heisel W
Q&A with Thomas Sullivan: Medical education companies don't deserve media abuse
Reporting on Health: Antidote: New Ways to Investigate Untold Health Stories 2009 Oct 9
http://www.reportingonhealth.org/blogs/qa-thomas-sullivan-medical-education-companies-dont-deserve-media-abuse

HSL16789
Heisel W
Q&A with Thomas Sullivan: Part 2: Medical education companies don't deserve media abuse
Reporting on Health: Antidote: New Ways to Investigate Untold Health Stories 2009 Oct 9
http://www.reportingonhealth.org/blogs/qa-thomas-sullivan-part-2-medical-education-companies-dont-deserve-media-abuse

HSL16605
Okike K, Kocher MS, Wei EX, Mehlman CT, Bhandari M
Accuracy of Conflict-of-Interest Disclosures Reported by Physicians
NEJM 2009 Oct 8; 361:(15):1466-1474
http://content.nejm.org/cgi/content/full/361/15/1466

HSL16610
Winstein KJ
Orthopedists Fail to Disclose Payments
The Wall Street Journal 2009 Oct 8
http://online.wsj.com/article/SB10001424052748704252004574459423318094700.html

HSL16611
Edwards J
AstraZeneca's Fuzzy Seroquel Math: When 45% Gain Weight, It's 'Weight-Neutral'
BNet 2009 Oct 8
http://industry.bnet.com/pharma/10004691/astrazenecas-fuzzy-seroquel-math-when-45-gain-weight-its-weight-neutral/

HSL16612
Svensson P
Next: the pill bottle cap with a cell phone
The Associated Press 2009 Oct 8
http://articles.nydailynews.com/2009-10-08/news/17935370_1_bottle-cell-phone-pill

HSL16615
Crigger NJ
Just Say No
Physician Assistants 2009 Oct 8
http://physician-assistant.advanceweb.com/editorial/content/editorial.aspx?cc=207949

HSL16618
Dizikes C
Franken bill would end company tax breaks for pharmaceutical marketing
MinnPost.com 2009 Oct 8
http://www.minnpost.com/cynthiadizikes/2009/10/08/12344/franken_bill_would_end_company_tax_breaks_for_pharmaceutical_mar

Page 3 of 20 pages  < 1 2 3 4 5 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963